Published November 8, 2011
| Version v1
Patent
Open
Methods for treating demyelination disorders
Contributors
Patent applicant:
Description
This invention is in the field of neurology. Specifically, the invention relates to the discovery and characterization of molecular components that play a role in neuronal demyelination or remyelination. In addition, the invention relates to the generation of an animal model that exhibits hypomyelination. The compositions and methods embodied in the present invention are particularly useful for drug screening and/or treatment of demyelination disorders.
Files
US8053627.pdf
Files
(4.6 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:96170da119e5c45fe9648a458f7b68d4
|
4.6 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 43178206 A
- Patent number
- US 8053627 B2
- Other
- oai:uchicago.tind.io:9184
Dates
- Patent filed
-
2006-05-09